Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Antengene and MSD Collaborate on Global Clinical Study for ATG-037

January 27, 2025
CompanyDrug

IASO Biotherapeutics Receives FDA Approval for CT103A IND Application

January 27, 2025
CompanyDeals

Shenzhen Würzburg Dynamics Raises RMB 100 Million in Series A Financing Round

January 27, 2025
CompanyDeals

AcornMed Raises RMB 200 Million in Series B Financing Led by Yikai Venture Capital

January 27, 2025
CompanyDrug

CSPC’s NBL-020 Receives FDA IND Approval for Advanced Solid Tumors

January 27, 2025
CompanyDrug

Jiangsu Chia Tai Tianqing’s TQB2102m Gains NMPA Clinical Approval

January 27, 2025
CompanyDeals

WuXi XDC Partners with GeneQuantum for ADC Development

January 27, 2025
CompanyDrug

Hengrui Pharmaceuticals Receives New Approval for Remimazolam Tosylate

August 26, 2025
CompanyDeals

Neurophth Partners with Apellis for Gene Therapy Development in AMD

January 27, 2025
CompanyDrug

Jing Medicine’s HJM-353 Gains Clinical Trial Approvals in US and China

January 27, 2025
CompanyDeals

Jiangsu Vcare PharmaTech Raises RMB 200 Million in Series B Financing Round

January 27, 2025
CompanyDrug

MindRank AI Receives FDA Approval for MDR-001 Clinical Study in Obesity

January 27, 2025
1 2 3 4 5 6 7 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up